#hebomab

1 articles

PCSK9 Inhibitors vs. Bempedoic Acid: Which Is Better for Long-Term Cholesterol Management?

Hypercholesterolemia remains a leading modifiable risk factor for cardiovascular disease worldwide. In China, the prevalence of dyslipidemia continues...

Mar 21, 2026

AI Medical Advisor

Hello! I'm ChinaMedical AI Assistant. I can help you with information about medical tourism in China, hospital recommendations, treatment costs, medical visas, and more. How can I help you?